期 |
栏目 |
标题 |
文件 |
卷 15, 编号 2 (2013) |
Articles |
Genital herpes: treatment options |
|
卷 15, 编号 4 (2013) |
Articles |
Vulvovaginitis and vaginosis treatment: clinical and laboratory efficiency |
|
卷 16, 编号 5 (2014) |
Articles |
The possibility of using antiviral drugs with immunomodulatory effects in treating HPV-associated diseases |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 16, 编号 6 (2014) |
Articles |
Antiviral therapy for recurrent genital herpes |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 16, 编号 5 (2014) |
Articles |
Genital infections and local medications of complex use (application experiences) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 19, 编号 5 (2017) |
Articles |
HPV-associated diseases of the cervix. Complex therapy options |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 21, 编号 1 (2019) |
Articles |
Local cytokine therapy in a comprehensive treatment of HPV-associated cervical diseases |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 21, 编号 6 (2019) |
REVIEW |
Biomarkers of cervicovaginal fluid for the diagnosis of cervical diseases associated with human papilloma virus (literature review) |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 22, 编号 4 (2020) |
BEST PRACTICE |
Vulvovaginitis of mixed etiology and real clinical practice |
![PDF](/img/labels/pdf.png) (Rus)
|
卷 25, 编号 3 (2023) |
PRACTICAL EXPERIENCE |
Management of patients with vulvovaginal atrophy and cytological abnormalities |
![PDF](/img/labels/pdf.png) (Rus)
|